PATENT CLAIM ANALYSIS

Application Number: 15905835
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-12
Patent Classification: ["514", "450000"]

Abstract:
A method of treating a subject suffering from an angiogenesis-related disease, which is implemented by administering to the subject a pharmaceutical composition comprising a compound of formula I derived from  Mitella formosana  to inhibit the angiogenic function of endothelial progenitor cells.

Claim (Index 5):
The method of  claim 1 , wherein the pharmaceutical composition further comprises at least one pharmaceutically acceptable carrier, adjuvant or excipient.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 88.0
- Lexical Diversity: 1.22857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14981178', '10328812', '15307812', '12522093', '11906137']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7146079241482346
- 35 USC 102 Novelty (BERT): 0.5116335442365346
- Combined Prediction Score: 0.6943104861570647
- Mean Citation Score: 183.390656
- Max Citation Score: 199.81577
- Similarity Product: 120.40338101980686

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test